What to check, what to ask, and how to tell the difference between a quality manufacturer and a glossy website.
There are hundreds of companies selling peptides online. Some are legitimate GMP manufacturers with real quality systems. Others are middlemen reselling product they've never tested from sources they can't name. And from the outside, their websites look almost identical.
If you're a compounding pharmacy, clinic, telehealth platform, or research institution sourcing peptide APIs, the supplier you choose is the single biggest variable affecting product quality, patient safety, and your regulatory exposure. A bad supplier doesn't just mean a bad batch — it means potential FDA warning letters, patient harm, and the kind of liability that ends careers.
This guide walks through every step of the vetting process, from the first Google search to ongoing quality monitoring after you've placed your first order. It's written for procurement professionals who source peptides — not for marketing departments.
Before you evaluate a single supplier, get clear on what you need. This sounds obvious, but it's where most sourcing mistakes start. Different use cases require fundamentally different supply chains.
If peptides are going into patients, you need pharmaceutical-grade API from a GMP-certified facility. No exceptions. The supplier must provide full batch documentation including Certificate of Analysis (CoA) with HPLC purity ≥98%, mass spectrometry identity confirmation, endotoxin testing (for injectables), heavy metal panels, and residual solvent testing.
The regulatory standard isn't "the peptide is mostly pure." It's "every batch is documented to pharmaceutical standards, and you can prove it during an audit."
For 503A pharmacies specifically, you're responsible for verifying that your API sources meet USP standards. For 503B outsourcing facilities, the bar is even higher — you need to demonstrate cGMP compliance throughout your entire supply chain, including your raw material suppliers.
For in-vitro studies, cell culture, or non-clinical research, you don't necessarily need pharmaceutical-grade material. Research-grade peptides with HPLC purity ≥95% and mass spectrometry confirmation are usually sufficient. The documentation requirements are lighter, the pricing is lower, and the lead times are often shorter.
But here's the thing: research-grade suppliers should never be used for clinical compounding, even if the purity numbers look good. The difference isn't just purity — it's the entire quality system behind the product. GMP manufacturing involves validated processes, environmental monitoring, equipment calibration, change control, deviation management, and ongoing stability testing. Research-grade manufacturing involves making the peptide and testing it. That's a huge gap.
For more on the differences, see our GMP vs Research Grade guide.
Every peptide supplier claims to be "GMP certified" on their website. Most of these claims are worth exactly nothing until you verify them independently.
GMP (Good Manufacturing Practice) is a set of regulations governing pharmaceutical manufacturing. In the US, it's defined under 21 CFR Parts 210 and 211. In the EU, it's EU GMP Annex guidelines. In China (where most peptide APIs are manufactured), it's NMPA GMP certification.
A real GMP certificate is issued by a regulatory authority — the FDA, EMA, NMPA, or their designated inspection bodies. It's not a badge a company puts on their website. It's a document issued after a facility passes an official inspection.
Ask the supplier for a copy of their current GMP certificate. Then verify it independently:
If a supplier can't produce a certificate, or the certificate is expired, or they give you a runaround about "confidential documentation," walk away. This isn't a gray area.
Self-issued "GMP certificates" that are just a company letterhead with a claim. Certificates from private auditing firms rather than regulatory authorities — ISO certificates serve a different purpose and are not the same as GMP certification. Certificates that list a different facility address than where the product is actually manufactured. Expired certificates with promises that "renewal is in progress." Any supplier who gets defensive when you ask for this documentation.
For a deeper understanding of GMP standards, PeptideBond's sourcing guide breaks down the regulatory frameworks in detail.
The CoA is the single most important document in peptide sourcing. It tells you what's in the vial. But not all CoAs are equal, and reading one properly takes practice.
A proper CoA for a peptide API includes the peptide name and sequence, batch/lot number, date of manufacture, date of testing, HPLC purity result (with method details — C18 column, gradient conditions, detection wavelength), mass spectrometry data confirming molecular identity (expected MW vs observed MW), appearance description, water content (Karl Fischer), peptide content, and endotoxin testing for injectable-grade material.
Each test result should have an acceptance criterion next to the actual result. "Purity: ≥98.0%. Result: 99.2%." If the CoA just says "Pass" without showing actual numbers, that's a problem.
A CoA from the manufacturer tells you what the manufacturer says about their own product. That's useful, but it's self-reported data. The gold standard is sending a sample to a third-party lab — Janoshik Analytical, Freedom Diagnostics, or MZ Biolabs — and comparing their results to the manufacturer's CoA.
If you're evaluating a new supplier, independent testing on your first batch is worth the $150-350 cost per compound. If the third-party results match the manufacturer's CoA within ±1-2% on purity, you've validated the supplier's quality system. If the numbers don't match, you've saved yourself from something worse than a wasted test fee.
Purity listed as exactly 99.0% or 99.9% on every batch (real analytical results have natural variation). No batch number, or a batch number that doesn't match the label. Testing date older than the manufacturing date (can't test what hasn't been made yet). Missing test methods. Results identical across multiple batches (copy-paste job). A CoA format that doesn't match the facility's other documentation.
Documentation can be faked. Track records are harder to fabricate.
A supplier who's been manufacturing peptide APIs for 10 years and still has clients is telling you something. They've survived regulatory inspections, market shifts, and the attrition that kills unreliable operators. A company that showed up six months ago with a polished website and aggressive pricing might be fine — or they might be a broker reselling product from unknown sources. Longevity isn't proof of quality, but it's a useful signal.
Legitimate manufacturers are usually willing to share references or at least describe the types of organizations they supply. "We supply several 503B outsourcing facilities in the US" means something — those facilities are FDA-inspected and can't survive with bad API sources. "We can't share any client information" might be legitimate or might mean they don't have clients worth naming.
The FDA publishes warning letters and import alerts publicly. If a supplier has received either, it doesn't automatically disqualify them — what matters is the violation, when it happened, and what corrective actions followed. A resolved warning letter from three years ago is different from an active import alert.
For Chinese manufacturers, check Import Alert 66-40 (insanitary conditions) and Alert 99-32 (unapproved drugs).
This is why PeptideBondReviews.com exists. Verified purchase reviews from other pharmacies and clinics tell you what actually happened when someone placed an order. Did the product arrive on time? Did the CoA match independent testing? How did the supplier handle a problem? That's information no CoA can give you.
This sounds soft compared to GMP certificates and CoA analysis, but it's one of the most reliable predictors of a good supplier relationship.
Send the supplier specific technical questions. Not "tell me about your company" — actual questions that require knowledge to answer. Ask about their synthesis method for a specific peptide. Ask about their endotoxin testing protocol. Ask about cold chain shipping. Ask what happens if you receive an out-of-spec batch.
Time the response. A good supplier replies within 1-2 business days with specific answers. Red flags: canned marketing responses that dodge your actual questions, weeks of silence followed by a sales pitch, or someone who clearly doesn't understand the technical details they're discussing.
A manufacturer should describe their quality assurance process without hesitation. What's their out-of-spec procedure? How do they handle deviations? What's their change control process? Do they test incoming raw materials? Do they have a stability program?
You're not looking for perfection — you're looking for evidence that these systems exist and get used. A supplier who says "we follow all applicable regulations" without being able to describe their processes is probably reading from a script.
Never place a large first order with a new supplier. Basic supply chain risk management — but surprising how often people skip it because the pricing is attractive.
Order one or two compounds at minimum quantities. When it arrives, check the packaging (proper labeling, temperature indicators if applicable, desiccants), verify the CoA matches the batch, and send at least one sample to an independent lab. This trial costs a fraction of what a failed large order would cost, and it tells you everything about the supplier's actual performance versus their marketing.
Track order date vs delivery date, packaging condition, CoA accuracy vs independent testing, communication quality, and how issues were handled. This is your supplier qualification file — you need one if you're a regulated entity, and you should have one even if you're not.
Qualifying a supplier isn't a one-time event.
After a few orders, you have enough data to evaluate consistency. Is purity staying within a narrow range? Are lead times predictable? Is documentation complete every time? Consistent results mean a process that's under control. Wildly varying results — even when each batch meets spec — suggest problems that haven't surfaced yet.
Even with a trusted supplier, periodic independent testing keeps everyone honest. Many regulated buyers test every incoming batch. At minimum, test annually or whenever something looks, dissolves, or performs differently than usual.
Once a year, formally review each supplier: on-time delivery rate, quality acceptance rate, responsiveness, corrective actions needed, and certification status. This is required for 503B facilities and smart practice for everyone else.
Never depend on a single supplier for a critical compound. Qualify at least two sources for your highest-volume peptides. Factory shutdowns, regulatory holds, and shipping disruptions happen. If your only supplier goes down, you need a plan B that doesn't involve scrambling.
Peptide API pricing varies enormously, and the cheapest option is almost never the cheapest in the long run.
A gram of BPC-157 API might cost $30 from one supplier and $200 from another. Some of that gap is margin. But most of it reflects real differences in manufacturing standards, testing depth, and regulatory compliance. GMP costs more than non-GMP. Full analytical testing costs more than a quick HPLC. Running a quality management system with validated processes and trained people costs more than not having one.
When a supplier's pricing is way below market, ask yourself what they're skipping.
Many Chinese manufacturers quote FOB pricing — the price at their loading dock. You handle international shipping, customs, duties, and cold chain logistics. That adds 15-40% to the FOB price depending on volume and destination.
Some suppliers handle the import logistics and deliver to your US location, which simplifies the process at a slightly higher unit cost. Whether FOB or delivered makes more sense depends on your volume, logistics experience, and whether you have a customs broker already.
One failed batch costs you the product, the testing, the time, the replacement order, and potentially patient trust. A regulatory citation from poorly documented API costs exponentially more. Price matters, but it's not the only number in the equation.
| Check | What to Look For | Red Flag |
|---|---|---|
| GMP Certificate | Current, issued by regulatory authority, facility address matches | Self-issued, expired, wrong address, never delivered |
| CoA Quality | Batch-specific, actual results with methods, acceptance criteria | Generic, "Pass" without numbers, identical across batches |
| Independent Testing | Results match CoA within ±1-2% purity | Purity 3%+ below stated, wrong molecular weight |
| Track Record | 2+ years in business, references available, no active FDA alerts | Brand new with aggressive pricing, no references, active warnings |
| Communication | 1-2 day response, technical knowledge, direct answers | Marketing fluff, dodges questions, weeks to respond |
| Pricing | Within market range for quality tier | Way below market with no clear reason |
| Documentation | Complete batch records, shipping records, stability data | Minimal paperwork, "we'll send it later," inconsistent formats |
That's what good sourcing looks like.
Your supplier suggestion helps our team evaluate options for, clinics, and practitioners make better sourcing decisions.
Suggest a Supplier →